granted
on 05 Jun 2024
Last Applicant/ Owned by
2121 2nd St, STE C108
Davis
CA
95618
Serial Number
97590689 filed on 14th Sep 2022
Registration Number
N/A
Correspondent Address
John Gary Maynard, III
John Gary Maynard, III HUNTON ANDREWS KURTH LLP
RIVERFRONT PLAZA, EAST TOWER
RICHMOND, VA 23219-4074
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prev Read More
Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; Development of computer platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; Development of computer platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; Platform as a service (PAAS) featuring predictive, monitoring and diagnostic computer software platforms for caregivers and healthcare providers to monitor health and wellness of pregnant women, nursing mothers, caregivers, and their infants; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and diseases
N/A
N/A
No 97590689
No Service Mark
No 084193.00002
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
Status Date | Action Taken |
---|---|
12th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
12th Dec 2024 | TEAS STATEMENT OF USE RECEIVED |
13th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
05th Jun 2024 | SOU EXTENSION 1 GRANTED |
05th Jun 2024 | SOU EXTENSION 1 FILED |
05th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
12th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
17th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
17th Oct 2023 | PUBLISHED FOR OPPOSITION |
27th Sep 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |